Titlebook: Learning Genitourinary and Pelvic Imaging; Joan C. Vilanova,Antonio Luna,Pablo R. Ros Book 2012 Springer-Verlag Berlin Heidelberg 2012 Gyn

papyrus

書目名稱Learning Genitourinary and Pelvic Imaging影響因子(影響力)




書目名稱Learning Genitourinary and Pelvic Imaging影響因子(影響力)學(xué)科排名




書目名稱Learning Genitourinary and Pelvic Imaging網(wǎng)絡(luò)公開度




書目名稱Learning Genitourinary and Pelvic Imaging網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Learning Genitourinary and Pelvic Imaging被引頻次




書目名稱Learning Genitourinary and Pelvic Imaging被引頻次學(xué)科排名




書目名稱Learning Genitourinary and Pelvic Imaging年度引用




書目名稱Learning Genitourinary and Pelvic Imaging年度引用學(xué)科排名




書目名稱Learning Genitourinary and Pelvic Imaging讀者反饋




書目名稱Learning Genitourinary and Pelvic Imaging讀者反饋學(xué)科排名

逗留

Carlos Nicolau,Carmen Sebastià,Blanca Pa?o Brufaungs.Explains the interconnections between nature and technolThis book is a resumption of the work “Integrated M/E Design: Building Systems Engineering” published by Anil Ahuja in 1997. Together with an international group of authors from the engineering, urban planning, and architecture fields, Mr.

壓倒

聽寫

Anthem

Joan C. Vilanova,Roberto García-Figueiras,Maria Boada,Joaquim Barcelós of these antagonists, unlike the agonists, differ substantially from that of LHRH. Five of the ten amino acids are unnatural and of D configuration. The structural combination of a hydrophobic N-terminus (residues 1, 2, and 3) and a basic/hydrophilic C-terminus (residues 6 and 8) was thought to be

Conscientious

Sandra Baleato,Gabriel C. Fernández,Joan C. Vilanovaons in cancer patients or in other patients with suppressed immune systems such as burn or surgical patients. The hematopoietic factors, chemokines, and interleukins, which stimulate host defense mechanisms, offer new therapeutic venues. Since the late 1980s, clinical trials of CSFs have demonstrate

使迷惑

SHOCK

MULTI

Friction

Guadalupe Garrido,Ignacio Alvarez Rey,Joan C. Vilanovaons in cancer patients or in other patients with suppressed immune systems such as burn or surgical patients. The hematopoietic factors, chemokines, and interleukins, which stimulate host defense mechanisms, offer new therapeutic venues. Since the late 1980s, clinical trials of CSFs have demonstrate